Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Leuk Lymphoma. 2022 Apr;63(4):903-910. doi: 10.1080/10428194.2021.2010064. Epub 2021 Nov 29.
The Prognostic Nutritional Index (PNI), a parameter combining serum albumin concentration and absolute lymphocyte count, is considered a measure of the nutritional and inflammatory status and the host's anti-tumor response. We analyzed the clinical characteristics and outcomes according to the PNI of 351 grades 1-3 A FL patients. Forty-one patients (12%) had a PNI ≤45, who were older and showed adverse baseline features. A low PNI was associated with a shorter PFS (only for patients >60 years), and OS (for all patients, 10-year OS, 52% versus 74%, = 0.0001). The prognostic impact of the PNI on OS was confirmed in a multivariate model for patients >60 years (HR = 3, = 0.006). In conclusion, the PNI is a readily accessible piece of information that can identify a small subset of FL patients with shorter survival, and it could be an aid to improve the nutritional status of patients prior to treatment initiation.
预后营养指数(PNI)是一种将血清白蛋白浓度和绝对淋巴细胞计数相结合的参数,被认为是衡量营养和炎症状态以及宿主抗肿瘤反应的指标。我们根据 351 例 1-3A 级滤泡性淋巴瘤(FL)患者的 PNI 分析了其临床特征和结局。41 例(12%)患者的 PNI ≤45,这些患者年龄较大,且具有不良的基线特征。低 PNI 与较短的无进展生存期(仅针对>60 岁的患者)和总生存期(所有患者,10 年 OS,52%比 74%,=0.0001)相关。对于>60 岁的患者,多变量模型证实了 PNI 对 OS 的预后影响(HR=3,=0.006)。总之,PNI 是一种易于获得的信息,可以识别出一小部分生存时间较短的 FL 患者,它可以帮助改善治疗前患者的营养状况。